MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy

Abstract excerpt

BACKGROUND: Cardiac allograft vasculopathy (CAV) remains the leading cause of morbidity and mortality after orthotopic heart transplantation (OHT). Because of its clinically silent progression and lack of symptoms, detection is often difficult and invasive coronary angiography is performed routinely. To date, there are no established noninvasive biomarkers available for prediction of CAV in transplanted...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to MicroRNA in disease regulation
• Share to Organ and Tissue Transplantation Research
• Share to Transplantation: Methods and Outcomes